• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《塞尔维亚接受直接经皮冠状动脉介入治疗及氯吡格雷治疗的ST段抬高型心肌梗死患者中与出血相关的CYP2C19基因分型分析》的勘误

Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.

作者信息

Novkovic Mirjana, Matic Dragan, Kusic-Tisma Jelena, Antonijevic Nebojsa, Radojkovic Dragica, Rakicevic Ljiljana

机构信息

Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, P.O. Box 23, Belgrade, 11010, Serbia.

Emergency Department, Clinic for Cardiology, Clinical Center of Serbia, Belgrade, Serbia.

出版信息

Eur J Clin Pharmacol. 2018 Apr;74(4):453. doi: 10.1007/s00228-018-2425-5.

DOI:10.1007/s00228-018-2425-5
PMID:29404632
Abstract

The correct Author names are shown in this paper.

摘要

本文中列出了正确的作者姓名。

相似文献

1
Correction to: Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.对《塞尔维亚接受直接经皮冠状动脉介入治疗及氯吡格雷治疗的ST段抬高型心肌梗死患者中与出血相关的CYP2C19基因分型分析》的勘误
Eur J Clin Pharmacol. 2018 Apr;74(4):453. doi: 10.1007/s00228-018-2425-5.
2
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study.ST段抬高型心肌梗死患者中CYP2C19基因分型指导的抗血小板治疗——直接经皮冠状动脉介入治疗（POPular）遗传学研究的原理与设计
Am Heart J. 2014 Jul;168(1):16-22.e1. doi: 10.1016/j.ahj.2014.03.006. Epub 2014 Mar 21.
3
A prospective randomized evaluation of a pharmacogenomic approach to antiplatelet therapy among patients with ST-elevation myocardial infarction: the RAPID STEMI study.ST段抬高型心肌梗死患者抗血小板治疗的药物基因组学方法的前瞻性随机评估：RAPID STEMI研究
Pharmacogenomics J. 2016 Feb;16(1):71-8. doi: 10.1038/tpj.2015.17. Epub 2015 Apr 7.
4
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.CYP2C19 和 ABCB1 单核苷酸多态性对替格瑞洛与氯吡格雷治疗急性冠脉综合征结局的影响：PLATO 试验的遗传亚研究。
Lancet. 2010 Oct 16;376(9749):1320-8. doi: 10.1016/S0140-6736(10)61274-3.
5
A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI.一项关于CYP2C19基因分型和血小板反应性检测对接受经皮冠状动脉介入治疗患者影响的研究。
Indian Heart J. 2015 Mar-Apr;67(2):114-21. doi: 10.1016/j.ihj.2015.03.017. Epub 2015 Apr 27.
6
CYP2C19 polymorphisms and coronary heart disease risk factors synergistically impact clopidogrel response variety after percutaneous coronary intervention.CYP2C19基因多态性与冠心病危险因素对经皮冠状动脉介入治疗后氯吡格雷反应多样性具有协同影响。
Coron Artery Dis. 2014 Aug;25(5):412-20. doi: 10.1097/MCA.0000000000000092.
7
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study.CYP2C19 多态性与稳定门诊患者缺血和出血结局的关系：CHARISMA 遗传学研究。
Eur Heart J. 2012 Sep;33(17):2143-50. doi: 10.1093/eurheartj/ehs059. Epub 2012 Mar 26.
8
Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.细胞色素 2C19 多态性携带与高维持剂量（150mg/天）氯吡格雷治疗后高血小板反应风险相关：根据基因多态性的双重剂量氯吡格雷加速血小板抑制（ACCEL-DOUBLE）研究结果。
JACC Cardiovasc Interv. 2010 Jul;3(7):731-41. doi: 10.1016/j.jcin.2010.05.007.
9
[Impact of proton pump inhibitor omeprazole on the antiplatelet effect of clopidogrel in individuals with various CYP2C19*2 genotypes].[质子泵抑制剂奥美拉唑对不同CYP2C19*2基因型个体氯吡格雷抗血小板作用的影响]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Aug;29(4):478-81. doi: 10.3760/cma.j.issn.1003-9406.2012.04.022.
10
Comparison of loading with maintenance dose of clopidogrel on platelet reactivity in Chinese with different CYP2C19 genotypes prior to percutaneous coronary intervention.经皮冠状动脉介入治疗前不同CYP2C19基因型中国患者中氯吡格雷负荷剂量与维持剂量对血小板反应性的比较。
Chin Med J (Engl). 2014;127(14):2571-7.

引用本文的文献

1
miR-6076 rs1463411 polymorphisms are associated with bleeding during clopidogrel treatment in patients with acute coronary syndrome.miR-6076 rs1463411 多态性与急性冠脉综合征患者氯吡格雷治疗期间出血相关。
Eur J Med Res. 2023 Feb 24;28(1):96. doi: 10.1186/s40001-023-01068-9.